219 related articles for article (PubMed ID: 27901054)
1. Functional defects in CD4
Guo H; Zheng M; Zhang K; Yang F; Zhang X; Han Q; Chen ZN; Zhu P
Sci Rep; 2016 Nov; 6():37559. PubMed ID: 27901054
[TBL] [Abstract][Full Text] [Related]
2. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
[TBL] [Abstract][Full Text] [Related]
3. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
[TBL] [Abstract][Full Text] [Related]
4. Decreased regulatory function of CD4
Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
[TBL] [Abstract][Full Text] [Related]
5. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.
Franceschini D; Paroli M; Francavilla V; Videtta M; Morrone S; Labbadia G; Cerino A; Mondelli MU; Barnaba V
J Clin Invest; 2009 Mar; 119(3):551-64. PubMed ID: 19229109
[TBL] [Abstract][Full Text] [Related]
7. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.
Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A
Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of regulatory T cells in patients with ankylosing spondylitis is associated with a loss of Tim-3.
Wang M; Liu C; Bond A; Yang J; Zhou X; Wang J; Ji B
Int Immunopharmacol; 2018 Jun; 59():53-60. PubMed ID: 29625390
[TBL] [Abstract][Full Text] [Related]
9. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
[TBL] [Abstract][Full Text] [Related]
10. Functional Modulation of Regulatory T Cells by IL-2.
Moon BI; Kim TH; Seoh JY
PLoS One; 2015; 10(11):e0141864. PubMed ID: 26529512
[TBL] [Abstract][Full Text] [Related]
11. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.
Garg G; Tyler JR; Yang JH; Cutler AJ; Downes K; Pekalski M; Bell GL; Nutland S; Peakman M; Todd JA; Wicker LS; Tree TI
J Immunol; 2012 May; 188(9):4644-53. PubMed ID: 22461703
[TBL] [Abstract][Full Text] [Related]
12. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
[TBL] [Abstract][Full Text] [Related]
13. In vivo maintenance of human regulatory T cells during CD25 blockade.
Huss DJ; Mehta DS; Sharma A; You X; Riester KA; Sheridan JP; Amaravadi LS; Elkins JS; Fontenot JD
J Immunol; 2015 Jan; 194(1):84-92. PubMed ID: 25416807
[TBL] [Abstract][Full Text] [Related]
14. PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.
Li Z; Lin F; Zhuo C; Deng G; Chen Z; Yin S; Gao Z; Piccioni M; Tsun A; Cai S; Zheng SG; Zhang Y; Li B
J Biol Chem; 2014 Sep; 289(39):26872-26881. PubMed ID: 25096571
[TBL] [Abstract][Full Text] [Related]
15. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
Zhang Y; Wang HB; Chi LJ; Wang WZ
Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
[TBL] [Abstract][Full Text] [Related]
16. Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response.
Ciccia F; Accardo-Palumbo A; Giardina A; Di Maggio P; Principato A; Bombardieri M; Rizzo A; Alessandro R; Ferrante A; Principe S; Peralta S; Conte F; Drago S; Craxì A; De Leo G; Triolo G
Arthritis Rheum; 2010 Dec; 62(12):3625-34. PubMed ID: 20722024
[TBL] [Abstract][Full Text] [Related]
17. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.
Passerini L; Allan SE; Battaglia M; Di Nunzio S; Alstad AN; Levings MK; Roncarolo MG; Bacchetta R
Int Immunol; 2008 Mar; 20(3):421-31. PubMed ID: 18270368
[TBL] [Abstract][Full Text] [Related]
18. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis.
Kotsianidis I; Nakou E; Bouchliou I; Tzouvelekis A; Spanoudakis E; Steiropoulos P; Sotiriou I; Aidinis V; Margaritis D; Tsatalas C; Bouros D
Am J Respir Crit Care Med; 2009 Jun; 179(12):1121-30. PubMed ID: 19342412
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
[TBL] [Abstract][Full Text] [Related]
20. Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis.
Appel H; Wu P; Scheer R; Kedor C; Sawitzki B; Thiel A; Radbruch A; Sieper J; Syrbe U
J Rheumatol; 2011 Nov; 38(11):2445-51. PubMed ID: 21921098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
